Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Transplant ; 17(9): 2312-2325, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28276660

ABSTRACT

Despite the introduction of novel and more targeted immunosuppressive drugs, the long-term survival of kidney transplants has not improved satisfactorily. Early antigen-independent intragraft inflammation plays a critical role in the initiation of the alloimmune response and impacts long-term graft function. Complement activation is a key player both in ischemia/reperfusion injury (IRI) as well as in adaptive antigraft immune response after kidney transplantation. Since the alternative pathway (AP) amplifies complement activation regardless of the initiation pathways and renal IR injured cells undergo uncontrolled complement activation, we speculated whether selective blockade of AP could be a strategy for prolonging kidney graft survival. Here we showed that Balb/c kidneys transplanted in factor b deficient C57 mice underwent reduced IRI and diminished T cell-mediated rejection. In in vitro studies, we found that fb deficiency in T cells and dendritic cells conferred intrinsic impaired alloreactive/allostimulatory functions, respectively, both in direct and indirect pathways of alloantigen presentation. By administering anti-fB antibody to C57 wt recipients in the early post Balb/c kidney transplant phases, we documented that inhibition of AP during both ischemia/reperfusion and early adaptive immune response is necessary for prolonging graft survival. These findings may have implication for the use of AP inhibitors in clinical kidney transplantation.


Subject(s)
Complement Activation/immunology , Complement Factor B/deficiency , Graft Rejection/prevention & control , Graft Survival/immunology , Kidney Transplantation/adverse effects , Reperfusion Injury/prevention & control , T-Lymphocytes/immunology , Allografts , Animals , Complement Factor B/genetics , Graft Rejection/etiology , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Knockout , Reperfusion Injury/etiology
2.
Am J Transplant ; 12(9): 2373-83, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22642544

ABSTRACT

Multipotent mesenchymal stromal cells (MSC) have recently emerged as promising candidates for cell-based immunotherapy in solid-organ transplantation. However, optimal conditions and settings for fully harnessing MSC tolerogenic properties need to be defined. We recently reported that autologous MSC given posttransplant in kidney transplant patients was associated with transient renal insufficiency associated with intragraft recruitment of neutrophils and complement C3 deposition. Here, we moved back to a murine kidney transplant model with the aim to define the best timing of MSC infusion capable of promoting immune tolerance without negative effects on early graft function. We also investigated the mechanisms of the immunomodulatory and/or proinflammatory activities of MSC according to whether cells were given before or after transplant. Posttransplant MSC infusion in mice caused premature graft dysfunction and failed to prolong graft survival. In this setting, infused MSC localized mainly into the graft and associated with neutrophils and complement C3 deposition. By contrast, pretransplant MSC infusion induced a significant prolongation of kidney graft survival by a Treg-dependent mechanism. MSC-infused pretransplant localized into lymphoid organs where they promoted early expansion of Tregs. Thus, pretransplant MSC infusion may be a useful approach to fully exploit their immunomodulatory properties in kidney transplantation.


Subject(s)
Kidney Transplantation/immunology , Mesenchymal Stem Cells/immunology , Animals , Graft Survival , Immunohistochemistry , Immunotherapy , Mice , Mice, Inbred BALB C
3.
Kidney Int ; 71(11): 1132-41, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17377507

ABSTRACT

We previously demonstrated the presence of regulatory T cells (Tregs) in lymph nodes (LNs) from rats made tolerant to a kidney allograft by donor peripheral blood mononuclear cell (PBMC) infusion. Here, we investigated the origin of Treg and characterized their phenotype and mechanisms underlying their suppressive effect. At different points after PBMC infusion, thymus, LN, and graft-infiltrating -lymphocyte's (GIL) alloreactivity was evaluated in mixed lymphocyte reaction (MLR), coculture, and transwell experiments. GIL phenotype (by fluorescence-activated cell sorting and immunohistochemistry) and cytokines mRNA expression were analyzed. Before transplantation, CD4(+) thymocytes and LN cells from donor PBMC-infused rats showed a reduced anti-donor but a normal anti-third-party proliferation. Anti-donor hyporesponsiveness was reverted by interleukin (IL)-2. CD4(+) thymocytes had no regulatory activity on a naïve MLR. Treg appeared in LN at 60 days post-transplant. CD4(+)-GIL isolated early (5 days) and late post-transplant (days 60-80) were hyporesponsive and suppressed a naïve MLR. IL-10 mRNA was upregulated in GIL and an anti-IL-10 monoclonal antibody reverted their inhibitory effect. Cell-to-cell contact potentiated the suppressive activity of CD4(+)-GIL. We suppose that allograft tolerance in this model is mediated by pretransplant generation of anergic cells in the thymus, which may have a permissive role to prevent early graft disruption. The healed graft is a source of donor antigens, which led to early selection of Treg. In the late phase, tolerance is maintained by appearance of Treg in LN.


Subject(s)
Kidney Transplantation/immunology , Lymphocyte Transfusion , Tissue Donors , Transplantation Tolerance/physiology , Transplants , Animals , CD4-Positive T-Lymphocytes/immunology , Coculture Techniques , Flow Cytometry , Immunohistochemistry , Immunophenotyping , Immunosuppression Therapy , Interleukin-10/immunology , Interleukin-2/immunology , Lymph Nodes/immunology , Lymphocyte Culture Test, Mixed , Male , RNA, Messenger/metabolism , Rats , Rats, Inbred BN , Rats, Inbred Lew , Rats, Inbred Strains , T-Lymphocytes, Regulatory/immunology , Thymus Gland/immunology , Time Factors , Transplantation, Homologous/immunology
4.
Parasite Immunol ; 23(11): 587-97, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11703810

ABSTRACT

The mechanisms by which antibodies interfere with Plasmodium growth are still under debate. Characterizing the asexual erythrocyte stages susceptible to antibodies from hyperimmune individuals is therefore a relevant contribution to vaccine research. In this study, using a virulent and synchronous murine malaria parasite, Plasmodium chabaudi chabaudi AJ, we have shown that trophozoites and circulating schizonts are not the main targets for antibodies from hyperimmune serum. In drug-cured mice challenged with a high inoculum of ring-infected erythrocytes, parasitemias do not decline until the moment of erythrocyte rupture, suggesting that effector mechanisms operate immediately prior to reinvasion. Confirming these findings, treatment of primary-infected mice with hyperimmune serum inhibited the generation of new ring forms, but did not alter the numbers of schizont-infected erythrocytes, despite the fact that these cells were recognized by immunoglobulin (Ig)G antibodies. When these mice were treated with IgG1 or IgG2a purified from hyperimmune serum, both subclasses limited reinvasion, but IgG2a showed a stronger protective activity. The fact that Fc digestion decreases but does not abrogate protection suggests that both Fc-dependent and independent mechanisms participate in this process. Treatment with cobra venom factor did not interfere with the antibody-mediated protection, ruling out the participation of the complement system in both lysis and phagocytosis of merozoites or infected erythrocytes. Therefore, in mice suffering from P. c. chabaudi AJ malaria, merozoite neutralization seems to be a major mechanism of protection conferred by hyperimmune serum antibodies. However, FcgammaR-mediated interactions, or other mechanisms not yet defined, may also contribute to inhibit erythrocyte reinvasion.


Subject(s)
Antibodies, Protozoan/immunology , Erythrocytes/parasitology , Immune Sera/immunology , Immunoglobulin Fab Fragments/immunology , Immunoglobulin G/immunology , Malaria/immunology , Plasmodium chabaudi/immunology , Animals , Disease Models, Animal , Dose-Response Relationship, Immunologic , Female , Immunization, Passive , Immunoglobulin Fab Fragments/therapeutic use , Immunoglobulin G/therapeutic use , Life Cycle Stages/immunology , Malaria/parasitology , Mice , Mice, Inbred BALB C , Parasitemia/immunology , Plasmodium chabaudi/growth & development , Time Factors
5.
Toxicon ; 36(2): 257-67, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9620574

ABSTRACT

Bothrops atrox snake venoms from two different Amazon regions, i.e., Manaus, AM (3 degrees 0.6'40"S; 60 degrees 0.1'6.0"W) and Tucurui, PA (3 degrees 0.42'30"S; 49 degrees 0.41'45"W), were analyzed with respect to the thrombin-like activity component by elution profile on gel-filtration and reverse phase HPLC chromatography, electrophoretic mobility on SDS-PAGE, and enzymatic activity on fibrinogen. Despite some individual discrepancies among venom specimens, the thrombin-like activity present in the Manaus pool was eluted earlier compared with the Tucurui pool but its enzymatic specific activity on thrombin was lower (s.a. = 6.0) than that observed in the Tucurui pool (s.a. = 134.0). However, the electrophoretic mobilities of the pools were similar, with most protein bands being concentrated around three main regions, i.e., protein bands with an apparent mr of 100 kDa, of 38-37 kDa and 30 kDa. However, no significant differences were observed in amidolytic activity on the synthetic substrate Tos-Gly-Pro-Arg-pNa, and there was no correlation between thrombin-like and amidolytic activities. A 32 kDa protein endowed with thrombin-like activity and specific activity of 2444 recognized and neutralized by horse anti-B. atrox antivenom, was purified by the successive use of gel filtration, electrofocusing and reverse phase HPLC.


Subject(s)
Blood Coagulation/drug effects , Bothrops , Snake Venoms/isolation & purification , Snake Venoms/pharmacology , Animals , Brazil , Cattle , Chromatography, Gel , Chromatography, High Pressure Liquid , Electrophoresis, Polyacrylamide Gel , Female , Horses , Mice , Mice, Inbred BALB C , Snake Venoms/enzymology
6.
Am J Trop Med Hyg ; 52(6): 516-20, 1995 Jun.
Article in English | MEDLINE | ID: mdl-7611557

ABSTRACT

Highly purified Trypanosoma-decay accelerating factor (T-DAF), a 87-93-kD glycoprotein present on the surface of metacyclic and trypomastigote forms of Trypanosoma cruzi, was used as antigen to evaluate the presence of specific serum antibodies in experimentally infected mice and patients with Chagas' disease by enzyme-linked immunosorbent assay (ELISA). Mouse T-DAF antibodies were first recorded on day 7 postinfection, reached maximal concentration on day 30, and maintained at positive titers thereafter. High immunogenicity was clearly demonstrated by the detection of T-DAF antibodies in 96% of the sera collected from chagasic patients in either the acute or the chronic phase of disease. Control sera from normal individuals and from patients with leishmaniasis or other chronic infections did not give positive results. Serologic evaluation using T-DAF as antigen did not discriminate between patients with the cardiac and the digestive forms of the disease. The performance of the T-DAF ELISA was compared with that of conventional screening tests for Chagas' disease (indirect immunofluorescence and hemagglutination). The T-DAF ELISA test showed a sensitivity of 96%, a specificity of 100%, an efficiency of 99%, a positive predicted value of 100%, a negative predicted value of 98%, and a kappa index of 0.96, thus indicating that it can be successfully used for the serodiagnosis of T. cruzi infection in humans.


Subject(s)
Antibodies, Protozoan/blood , Antigens, CD/immunology , Chagas Disease/immunology , Complement Inactivator Proteins/immunology , Membrane Glycoproteins/immunology , Trypanosoma cruzi/immunology , Animals , Antigens, Protozoan/immunology , Chagas Disease/diagnosis , Enzyme-Linked Immunosorbent Assay , Female , Humans , Mice , Protozoan Proteins/immunology , Sensitivity and Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...